Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer

Protein phosphatase 2A (PP2A) is a tumor suppressor complex that has recently been reported as a novel and highly relevant molecular target in prostate cancer (PCa). However, its potential therapeutic value remains to be fully clarified. We treated PC-3 and LNCaP cell lines with the PP2A activators...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mar Drugs
Asıl Yazarlar: Cristóbal, Ion, González-Alonso, Paula, Daoud, Lina, Solano, Esther, Torrejón, Blanca, Manso, Rebeca, Madoz-Gúrpide, Juan, Rojo, Federico, García-Foncillas, Jesús
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4483628/
https://ncbi.nlm.nih.gov/pubmed/26023836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/md13063276
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller